AIM: To investigate the protective effects of octacosanol in 6-hydroxydopamine-induced Parkinsonian rats and find whether octacosanol has effects on pro nerve growth factor (pro-NGF), NGF and the downstream effector proteins. METHODS: Behavioral tests, enzymatic assay, tyrosine hydroxylase immunohistochemistry, TUNEL and Western blot were used to investigate the effects of octacosanol in this rat model of PD. RESULTS: Oral administration of octacosanol (35-70 mg/kg, po for 14 d) significantly improved the behavioral impairments in rats induced by 6-OHDA and dose-dependently preserved the free radical scavenging capability of the striatum. Octacosanol treatment also effectively ameliorated morphological appearances of TH-positive neuronal cells in nigrostriatal systems and decreased the apoptotic cells induced by 6-OHDA in striatum. In addition, octacosanol strikingly blocked the 6-OHDA-induced increased expression of proNGF-p75NTR-sortilin death signaling complex and its downstream effector proteins. Meantime, octacosanol prevented the decreased levels of NGF, its receptors TrkA and p-Akt which together mediated the cell survival pathway. CONCLUSION: The findings implicated that the anti-parkinsonism effects afforded by octacosanol might be mediated by its neuro-microenvironment improving potency through retrieving the ratios of proNGF:NGF and the respective receptors p75NTR:TrkA in vivo. Due to its excellent tolerability and non-toxicity, octacosanol may be a promising agent for PD treatment.
AIM: To investigate the protective effects of octacosanol in 6-hydroxydopamine-induced Parkinsonianrats and find whether octacosanol has effects on pro nerve growth factor (pro-NGF), NGF and the downstream effector proteins. METHODS: Behavioral tests, enzymatic assay, tyrosine hydroxylase immunohistochemistry, TUNEL and Western blot were used to investigate the effects of octacosanol in this rat model of PD. RESULTS: Oral administration of octacosanol (35-70 mg/kg, po for 14 d) significantly improved the behavioral impairments in rats induced by 6-OHDA and dose-dependently preserved the free radical scavenging capability of the striatum. Octacosanol treatment also effectively ameliorated morphological appearances of TH-positive neuronal cells in nigrostriatal systems and decreased the apoptotic cells induced by 6-OHDA in striatum. In addition, octacosanol strikingly blocked the 6-OHDA-induced increased expression of proNGF-p75NTR-sortilin death signaling complex and its downstream effector proteins. Meantime, octacosanol prevented the decreased levels of NGF, its receptors TrkA and p-Akt which together mediated the cell survival pathway. CONCLUSION: The findings implicated that the anti-parkinsonism effects afforded by octacosanol might be mediated by its neuro-microenvironment improving potency through retrieving the ratios of proNGF:NGF and the respective receptors p75NTR:TrkA in vivo. Due to its excellent tolerability and non-toxicity, octacosanol may be a promising agent for PD treatment.
Authors: R Menéndez; R Más; A M Amor; R M González; J C Fernández; I Rodeiro; M Zayas; S Jiménez Journal: Br J Clin Pharmacol Date: 2000-09 Impact factor: 4.335
Authors: Marta Salinas; Raquel Diaz; Nader G Abraham; Carlos M Ruiz de Galarreta; Antonio Cuadrado Journal: J Biol Chem Date: 2003-02-10 Impact factor: 5.157
Authors: C L Alemán; R Más; C Hernández; I Rodeiro; E Cerejido; M Noa; A Capote; R Menéndez; A Amor; V Fraga Journal: Toxicol Lett Date: 1994-01 Impact factor: 4.372
Authors: Fatma Y Meligy; Dalia A Elgamal; Eman S H Abd Allah; Naglaa K Idriss; Nagwa M Ghandour; Ehab M R Bayoumy; Azza Sayed Abdelrehim Khalil; Mohamed M El Fiky; Mostafa Elkhashab Journal: Mol Biol Rep Date: 2019-08-08 Impact factor: 2.316
Authors: Bradley R Kraemer; Rachel T Clements; Cassandra M Escobedo; Kendall S Nelson; Carter D Waugh; Andrew S Elliott; Wesley C Hall; Montana T Schemanski Journal: Neuroscience Date: 2020-11-28 Impact factor: 3.590
Authors: Anderson Marques de Oliveira; Lucia M Conserva; Jamylle N De Souza Ferro; Fabíola de Almeida Brito; Rosângela P Lyra Lemos; Emiliano Barreto Journal: Int J Mol Sci Date: 2012-02-02 Impact factor: 6.208